Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER_GOV 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 4Pain, Postoperative 2Vomiting 1Urinary Incontinence, Stress 1Urinary Incontinence 1Urinary Bladder Neoplasms 1Shoulder Pain 1Psychomotor Agitation 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Ovarian Neoplasms 1Ovarian Cysts 1Neuroblastoma 1Neoplasms 1Myofibroma 1Menstruation Disturbances 1Lung Neoplasms 1Liver Neoplasms 1Laryngeal Neoplasms 1Head and Neck Neoplasms 1Gynecologic Oncology Patient 1Endometrial Neoplasms 1Cognitive Dysfunction 1Anxiety Disorders 1Advanced Breast Cancer 1

Interventions

Paclitaxel 177Carboplatin 177Bevacizumab 72Topotecan 55liposomal doxorubicin 54Gemcitabine 53Cisplatin 46Docetaxel 39Cyclophosphamide 37olaparib 32Filgrastim 31pembrolizumab 29Doxorubicin 26niraparib 24Taxes 23Drug Therapy 23Peripheral Blood Stem Cell Transplantation 20Etoposide 17veliparib 15Nivolumab 14sargramostim 13Surveys and Questionnaires 13Immunoglobulin G 13Disulfides 13pazopanib 12Ifosfamide 12Albumin-Bound Paclitaxel 12durvalumab 11atezolizumab 11Trabectedin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Ovarian Neoplasms × Population Groups × Clear all
NCT06629831 2024-10-09

Systemic Inflammatory Biomarkers in Ovarian Cancer

Bakirkoy Dr. Sadi Konuk Research and Training Hospital

Completed
90 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡